The Ainsworth Institute is one of just 26 sites in the nation selected to start performing the cutting-edge technology! DRG Stimulation is a variation of traditional spinal cord stimulation. The difference is that the leads are a fraction of the size and are placed directly over the individual nerves of the spine, more specifically, the small structures that house the neurons themselves - the Dorsal Root Ganglion (DRG). The ACCURATE study (an FDA-approved clinical trial performed by leading pain physicians in the United States) was completed in 2015 and the results were presented at the North American Neuromodulation Society meeting in the same year. The results were impressive to say the least! It showed DRG was superior in almost way to traditional stimulation with better success rates and better overall pain relief. Dr. Hunter has been selected as one of the…
Dr. Hunter just performed the first Invisible Spinal Cord Stimulator (SCS) Trial in the state of New York! The Invisible Trial system was developed by St Jude Medical and presents a major leap forward for the technology. This device interfaces with Apple devices allowing patients the ability to control their pain relief with the touch of a finger. What's even more impressive is the trial is totally wireless! Read more about the Invisible Trial System...
Drs. Hunter and Lee presented at the joint meeting of the New York and New Jersey Society of Interventional Pain Physicians (NYSIPP & NJSIPP). Dr. Hunter lectured on the use of Spinal Cord Stimulation (SCS) for Pelvic Pain. Dr. Lee was chosen to train physicians on the use of Radiofrequency Ablation (RFA) of joint pain.
The Ainsworth Institute is proud to announce is has joined the CREATE-1 Study: CRPS Treatment Evaluation 1 Study - sponsored by Axsome Therapeutics, Inc. This is an FDA approved trial studying the effects of a new groundbreaking oral medication to treat CRPS. Enrollment will start shortly.
Our doctors continued their 2015 lecture circuit, this time in Miami. Dr. Lee joined an expert council from around the country discussing RFA for joint pain and Dr. Hunter spoke about Testosterone deficiency in patients on chronic opioids, spinal cord stimulation for headaches and neck pain, and stem cells for degenerative disc disease.
The American Society of Interventional Pain Physicians is a not-for-profit organization representing interventional pain physicians across the country. The organization has been growing rapidly since 1998 and has had a substantial impact on the practice of interventional pain medicine. Read More
Pain Physician is a peer-reviewed journal that addresses the science and practice of interventional pain management. As the official publication of the American Society of Interventional Pain Physicians, Pain Physician outlines the latest studies, research and information vital to those in the growing specialty of interventional pain management – and critical to the people they serve. It is mailed quarterly to ASIPP members and other subscribers. Dr. Hunter has just joined the editorial staff where he will be responsible for reviewing manuscripts submitted for publication from around the world. Read More
St. Jude Medical is a medical device company on the forefront of innovation in a number of specialties, particularly pain management. Dr. Hunter accepted a position an official consultant and speaker for the company. He has now joined the ranks of some of the most well-respected and world-renowned pain management specialists from around the world to be a part of their team.
For the second time this year, Dr. Hunter was bestowed the privilege of giving grand rounds at the Pain Department at the Weill Cornell Medical Center. In attendance were doctors from New York-Presbyterian Hospital, Memorial Sloan Kettering Cancer Center, and Hospital for Special Surgery. Dr. Hunter's lecture was titled "Advances in Neuromodulation" where he discussed the current and future trends in the use of Spinal Cord Stimulation for the treatment of pain.
Dr. Hunter was promoted to the position of Secretary of NYSIPP by his peers and colleagues in honor of his accomplishments in the field of Pain Medicine and for his dedication to excellence. He served as Director-at-Large for 2 years prior. He was also also asked to join as faculty and lead an instructional workshop on teaching Microdiscectomy at this year's annual meeting.